Literature DB >> 1680573

Vecuronium is more potent in Montreal than in Paris.

P Fiset1, F Donati, P Balendran, C Meistelman, E Lira, D R Bevan.   

Abstract

This study was undertaken to compare the potency of vecuronium in patients anaesthetized in Montreal or Paris. Anaesthesia was induced with thiopentone and maintained with N2O, and intermittent boluses of thiopentone and fentanyl in 18 patients in Paris and 19 in Montreal. Neuromuscular blockade was measured using train-of-four stimulation of the ulnar nerve. The force of contraction of the adductor pollicis muscle was measured. Single doses of vecuronium, 20, 30, or 40 micrograms.kg-1 were given by random allocation. Dose response curves were constructed by obtaining the linear regression of the logit of the first response (T1) neuromuscular blockade versus log dose. The patients in Paris required 27% more vecuronium (95% confidence limits 5-53%; P = 0.01) for the same intensity of blockade. In Montreal, the ED50 and ED90 (+/- SEE for the mean) values were 26.0 +/- 1.4 and 44.2 +/- 2.5 micrograms.kg-1 compared with 33.0 +/- 3.3 and 71.9 +/- 7.2 micrograms.kg-1 in Paris respectively. The patients were comparable with respect to age, sex, height and weight. These results confirm, for vecuronium, the transatlantic difference in potency of neuromuscular blocking drugs which was previously observed with d-tubocurarine between London and New York.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680573     DOI: 10.1007/BF03008448

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  31 in total

1.  Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.

Authors:  R D Miller; M Crique; E I Eger
Journal:  Anesthesiology       Date:  1976-03       Impact factor: 7.892

2.  The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane.

Authors:  R D Miller; W L Way; W M Dolan; W C Stevens; E I Eger
Journal:  Anesthesiology       Date:  1972-12       Impact factor: 7.892

3.  Mutual potentiation of the neuromuscular effects of antibiotics and relaxants.

Authors:  L Burkett; G B Bikhazi; K C Thomas; D A Rosenthal; M G Wirta; F F Foldes
Journal:  Anesth Analg       Date:  1979 Mar-Apr       Impact factor: 5.108

4.  Cumulative dose-response with infusion: a technique to determine neuromuscular blocking potency of atracurium and vecuronium.

Authors:  C E Smith; F Donati; D R Bevan
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

5.  Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method.

Authors:  H Ording; L T Skovgaard; J Engbaek; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1985-01       Impact factor: 2.105

6.  Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.

Authors:  F M Gibson; R K Mirakhur; R S Clarke; G G Lavery
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

7.  Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.

Authors:  J Engbaek; H Ording; T Pedersen; J Viby-Mogensen
Journal:  Br J Anaesth       Date:  1984-09       Impact factor: 9.166

8.  Safety and efficacy of vecuronium in adolescents and children.

Authors:  N G Goudsouzian; J J Martyn; L M Liu; M Gionfriddo
Journal:  Anesth Analg       Date:  1983-12       Impact factor: 5.108

9.  Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia.

Authors:  O A Meretoja; K Wirtavuori; P J Neuvonen
Journal:  Anesth Analg       Date:  1988-01       Impact factor: 5.108

10.  Diphenhydramine in Orientals and Caucasians.

Authors:  R Spector; A K Choudhury; C K Chiang; M J Goldberg; M M Ghoneim
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

View more
  2 in total

1.  Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.

Authors:  Y Salib; J Frossard; B Plaud; B Debaene; C Meistelman; F Donati
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

2.  Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.

Authors:  Tiffany Woo; Kyo Sang Kim; Yon Hee Shim; Mi Kyeong Kim; Suk Min Yoon; Young Jin Lim; Hong Seuk Yang; Phillip Phiri; Jin Young Chon
Journal:  Korean J Anesthesiol       Date:  2013-12-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.